These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 35030969)
1. High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling. Xi X; Hu Z; Wu Q; Hu K; Cao Z; Zhou J; Liao J; Zhang Z; Hu Y; Zhong X; Bao Y Bioengineered; 2022 Jan; 13(1):1895-1907. PubMed ID: 35030969 [TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA Small Nucleolar RNA Host Gene 3 Mediates Prostate Cancer Migration, Invasion, and Epithelial-Mesenchymal Transition by Sponging miR-487a-3p to Regulate Yu L; Ren Y Cancer Biother Radiopharm; 2022 Aug; 37(6):451-465. PubMed ID: 33416420 [No Abstract] [Full Text] [Related]
3. SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis. Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912 [TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway. Shi J; Li J; Yang S; Hu X; Chen J; Feng J; Shi T; He Y; Mei Z; He W; Xie J; Li S; Jie Z; Tu S J Cell Physiol; 2020 Mar; 235(3):2891-2900. PubMed ID: 31602642 [TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer. Li T; Xing Y; Yang F; Sun Y; Zhang S; Wang Q; Zhang W Cancer Med; 2020 Jun; 9(11):3852-3862. PubMed ID: 32248648 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer. Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848 [TBL] [Abstract][Full Text] [Related]
7. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling. Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537 [No Abstract] [Full Text] [Related]
8. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer. Hong L; Chen W; Wu D; Wang Y Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-485-3p promotes proliferation, migration and invasion in prostate cancer through activation of TGF-β signaling. Chen D; Fan J; Li X; Jiao Z; Tang G; Guo X; Chen H; Wang J; Men T Histol Histopathol; 2022 May; 37(5):423-430. PubMed ID: 34958117 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling. Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541 [TBL] [Abstract][Full Text] [Related]
11. ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state. Kwon W; Choi SK; Kim D; Kim HG; Park JK; Han JE; Cho GJ; Yun S; Yu W; Han SH; Ha YS; Lee JN; Kwon TG; Cho DH; Yi JK; Kim MO; Ryoo ZY; Park S J Exp Clin Cancer Res; 2021 Sep; 40(1):291. PubMed ID: 34537073 [TBL] [Abstract][Full Text] [Related]
12. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis. Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106 [TBL] [Abstract][Full Text] [Related]
13. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone. Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177 [TBL] [Abstract][Full Text] [Related]
14. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway. Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201 [TBL] [Abstract][Full Text] [Related]
15. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1. Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847 [TBL] [Abstract][Full Text] [Related]
16. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis. Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306 [TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis. Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993 [TBL] [Abstract][Full Text] [Related]
18. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946 [TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG3 regulates the BMSC osteogenic differentiation in bone metastasis of breast cancer by modulating the miR-1273g-3p/BMP3 axis. Sun Z; Hu J; Ren W; Fang Y; Hu K; Yu H; Liao D; Liu S; Zhou L; He T; Zhang Y Biochem Biophys Res Commun; 2022 Feb; 594():117-123. PubMed ID: 35081500 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer. Hu CY; Chen J; Qin XH; You P; Ma J; Zhang J; Zhang H; Xu JD J Exp Clin Cancer Res; 2021 Mar; 40(1):98. PubMed ID: 33722248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]